Molecular Quality Controls Market Report and Forecast 2024-2032

The global molecular quality controls market size was valued at USD 186.7 million in 2023, driven by the increasing incidence of HIV and cancer across the globe. The market size is anticipated to grow at a CAGR of 6.8% during the forecast period of 2024-2032 to achieve a value of USD 337.1 million by 2032.

Molecular Quality Controls: Introduction

Molecular quality controls are essential tools used in molecular diagnostics and clinical laboratories to ensure the accuracy and reliability of test results. These controls serve as external verification samples containing target nucleic acids (like DNA or RNA) that mimic patient samples. By testing these controls alongside patient samples, laboratories can confirm that their diagnostic processes are functioning correctly and producing consistent and accurate results.

Key Trends in the Global Molecular Quality Controls Market

The global molecular quality controls market is undergoing dynamic shifts, largely driven by the rising emphasis on accurate and reliable diagnostic testing. A prominent trend is the increasing adoption of third-party independent controls, which provide an unbiased assessment of assay performance, gaining preference over manufacturer-provided controls. There's also a heightened demand for multi-analyte controls, allowing labs to verify multiple targets in a single control, thereby optimizing workflow and cost-efficiency.

With the rapid proliferation of molecular diagnostic tests, especially amid the COVID-19 pandemic, there's a marked surge in the demand for controls specific to emerging infectious diseases. Technological advancements have also ushered in the era of digital molecular controls, leveraging synthetic DNA sequences and bioinformatics for enhanced precision and reproducibility. Regulatory bodies worldwide are now emphasizing stricter guidelines, pushing laboratories to adopt frequent quality control measures. Moreover, the growth of personalized medicine and next-generation sequencing (NGS) techniques necessitates advanced controls to ensure the accuracy of complex diagnostic outputs. In essence, the global molecular quality controls market is evolving rapidly, shaped by technological innovations, regulatory mandates, and the ever-growing need for precise diagnostic assays.

Global Molecular Quality Controls Market Segmentation

Market Breakup by Product Type

• DNA- Based Quality Controls
• RNA Based Quality Control
• Protein-Based Quality Controls
• Nucleic Acid and Protein Mixtures
• Others

Market Breakup by Analyte Type

• Single Analyte Control
• Multi Analyte Control

Market Breakup by Applications

• Infectious Diseases
• Oncology
• Genetic Testing
• Other Applications

Market Breakup by End User

• Clinical Laboratories
• Hospitals
• IVD Manufacturers
• Contract Research Organizations
• Academic and Research Institutes

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Molecular Quality Controls Market Overview

The global molecular quality controls market is witnessing significant growth, underscored by the burgeoning demand for high-precision molecular diagnostic testing. This growth is reinforced by the increasing prevalence of infectious diseases, genetic disorders, and the broad acceptance of personalized medicine, all of which necessitate accurate diagnostic results. The market's landscape is further enriched by the emergence of third-party independent controls, offering an impartial evaluation of assay performance. These controls have become particularly relevant as they counteract potential biases associated with manufacturer-provided controls. The rapid response to emerging infectious diseases, as evidenced during the COVID-19 pandemic, has catapulted the demand for specialized quality controls, ensuring the reliability of newly developed tests.

Technological forays, including digital molecular controls and multi-analyte controls, are paving the way for enhanced efficiency and reproducibility. Concurrently, tightening regulatory frameworks globally are propelling laboratories towards more rigorous and consistent quality control measures. While North America dominates the market share due to its advanced diagnostic infrastructure and stringent regulatory norms, Asia Pacific regions are showcasing robust growth, fueled by rising healthcare investments and growing awareness about diagnostic accuracy. All in all, the global molecular quality controls market stands at the nexus of technological innovation, regulatory emphasis, and an ever-present need for diagnostic precision, making its growth trajectory promising and resilient.

Global Molecular Quality Controls Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Roche Diagnostics
• SeraCare Life Sciences, Inc.
• QIAGEN N.V.
• Abbott Laboratories
• LGC Limited
• ZeptoMetrix Corporation
• Microbiologics, Inc.
• Maine Molecular Quality Controls, Inc.
• Seracare Life Sciences, Inc.
• Technopath Clinical Diagnostics
• Randox Laboratories Ltd.
• Helena Laboratories
• Streck, Inc.

The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


This product will be delivered within 5-7 business days.